Biomedicine & Pharmacotherapy (Nov 2022)

The antitumor properties of atractylenolides: Molecular mechanisms and signaling pathways

  • Yu Jiang,
  • Kaibo Guo,
  • Peipei Wang,
  • Ying Zhu,
  • Jiaqi Huang,
  • Shanming Ruan

Journal volume & issue
Vol. 155
p. 113699

Abstract

Read online

Drugs that exhibit a high degree of tumor cell selectivity while minimizing normal cell toxicity are an area of active research interest as a means of designing novel antitumor agents. The pharmacological benefits of Chinese herbal medicine-based treatments have been the focus of growing research interest in recent years. Sesquiterpenoids derived from the Atractylodes macrocephala volatile oil preparations exhibit in vitro and in vivo antitumor activity. Atracylenolides exhibit anti-proliferative, anti-metastatic, and immunomodulatory activity in a range of tumor cell lines in addition to being capable of regulating metabolic activity such that it is a promising candidate drug for the treatment of diverse cancers. The present review provides a summary of recent advances in Atractylenolide-focused antitumor research efforts.

Keywords